These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 27467188)

  • 21. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
    Young J; Rey R; Schaison G; Chanson P
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
    Delemarre-van de Waal HA
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
    Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
    Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
    Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
    Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Puberty induction in boys with congenital isolated hypogonadotropic hypogonadism].
    Kokoreva KD; Chugunov IS; Kareva MA; Bezlepkina OB
    Probl Endokrinol (Mosk); 2023 Feb; 69(1):59-67. PubMed ID: 36842078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone.
    Bougnères P; François M; Pantalone L; Rodrigue D; Bouvattier C; Demesteere E; Roger D; Lahlou N
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2202-5. PubMed ID: 18381569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hCG-induced maturation of the seminiferous epithelium in hypogonadotropic men.
    D'Agata R; Heindel JJ; Vicari E; Aliffi A; Gulizia S; Polosa P
    Horm Res; 1984; 19(1):23-32. PubMed ID: 6420302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
    Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
    J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of spermatozoa after rFSH/hCG treatment, and subsequent ICSI/IVF, in a male with testicular atrophy due to severe congenital hypogonadotrophic hypogonadism.
    Nilsson S; Hellberg D
    Arch Androl; 2006; 52(2):135-8. PubMed ID: 16443591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism.
    Shankar RR; Shah S; Joeng HK; Mendizabal G; DiBello JR; Guan Y; Stegmann BJ; Nieschlag E; Behre HM; Swerdloff RS; Fox MC; Kaufman KD
    J Clin Endocrinol Metab; 2022 Jun; 107(7):2036-2046. PubMed ID: 35275602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.
    Alexander EC; Faruqi D; Farquhar R; Unadkat A; Ng Yin K; Hoskyns R; Varughese R; Howard SR
    Eur J Endocrinol; 2024 Jan; 190(1):S1-S11. PubMed ID: 38128110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions.
    Trabado S; Lamothe S; Maione L; Bouvattier C; Sarfati J; Brailly-Tabard S; Young J
    Ann Endocrinol (Paris); 2014 May; 75(2):79-87. PubMed ID: 24815726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism.
    Matsumoto AM; Snyder PJ; Bhasin S; Martin K; Weber T; Winters S; Spratt D; Brentzel J; O'Dea L
    Fertil Steril; 2009 Sep; 92(3):979-990. PubMed ID: 18930190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
    Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility induction in hypogonadotropic hypogonadal men.
    Prior M; Stewart J; McEleny K; Dwyer AA; Quinton R
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):712-718. PubMed ID: 30194850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.